Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience

Wing Bun Chan,1 Jung Fu Chen,2 Su-Yen Goh,3 Thi Thanh Huyen Vu,4 Iris Thiele Isip-Tan,5 Sony Wibisono Mudjanarko,6 Shailendra Bajpai,7 Maria Aileen Mabunay,7 Pongamorn Bunnag8 1Qualigenics Diabetes Centre, Hong Kong SAR, People’s Republic of China; 2Division of Metabolism, Department of In...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chan WB, Chen JF, Goh SY, Vu TTH, Isip-Tan IT, Mudjanarko SW, Bajpai S, Mabunay MA, Bunnag P
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	Diabetes Mellitus Long-acting Insulin Hypoglycemia Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/8776fe53e18f444398df06aa8b338b82
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8776fe53e18f444398df06aa8b338b82
record_format	dspace
spelling	oai:doaj.org-article:8776fe53e18f444398df06aa8b338b822021-12-02T01:38:31ZChallenges and unmet needs in basal insulin therapy: lessons from the Asian experience1178-7007https://doaj.org/article/8776fe53e18f444398df06aa8b338b822017-12-01T00:00:00Zhttps://www.dovepress.com/challenges-and-unmet-needs-in-basal-insulin-therapy-lessons-from-the-a-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Wing Bun Chan,1 Jung Fu Chen,2 Su-Yen Goh,3 Thi Thanh Huyen Vu,4 Iris Thiele Isip-Tan,5 Sony Wibisono Mudjanarko,6 Shailendra Bajpai,7 Maria Aileen Mabunay,7 Pongamorn Bunnag8 1Qualigenics Diabetes Centre, Hong Kong SAR, People’s Republic of China; 2Division of Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan; 3Department of Endocrinology, Singapore General Hospital, Singapore; 4Out-patient Department and Department of Internal Medicine, National Geriatric Hospital, Hanoi Medical University, Hanoi, Vietnam; 5Section of Endocrinology, Diabetes and Metabolism, University of the Philippines–Philippine General Hospital, Manila, Philippines; 6Diabetes and Nutrition Centre, Dr. Soetomo Hospital, School of Medicine Airlangga University, Surabaya, Indonesia; 7Sanofi, Singapore; 8Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand Abstract: Basal insulin therapy can improve glycemic control in people with type 2 diabetes. However, timely initiation, optimal titration, and proper adherence to prescribed basal insulin regimens are necessary to achieve optimal glycemic control. Even so, glycemic control may remain suboptimal in a significant proportion of patients. Unique circumstances in Asia (eg, limited resources, management of diabetes primarily in nonspecialist settings, and patient populations that are predominantly less educated) coupled with the limitations of current basal insulin options (eg, risk of hypoglycemia and dosing time inflexibility) amplify the challenge of optimal basal insulin therapy in Asia. Significant progress has been made with long-acting insulin analogs (insulin glargine 100 units/mL and insulin detemir), which provide longer coverage and less risk of hypoglycemia over intermediate-acting insulin (Neutral Protamine Hagedorn insulin). Furthermore, recent clinical evidence suggests that newer long-acting insulin analogs, new insulin glargine 300 units/mL and insulin degludec, may address some of the unmet needs of current basal insulin options in terms of risk of hypoglycemia and dosing time inflexibility. Nevertheless, more can be done to overcome barriers to basal insulin therapy in Asia, through educating both patients and physicians, developing better patient support models, and improving accessibility to long-acting insulin analogs. In this study, we highlight the unique challenges associated with basal insulin therapy in Asia and, where possible, propose strategies to address the unmet needs by drawing on clinical experiences and perspectives in Asia. Keywords: insulin titration, insulin detemir, insulin glargine, insulin degludec, patient educationChan WBChen JFGoh SYVu TTHIsip-Tan ITMudjanarko SWBajpai SMabunay MABunnag PDove Medical PressarticleDiabetes MellitusLong-acting InsulinHypoglycemiaSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 10, Pp 521-532 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diabetes Mellitus Long-acting Insulin Hypoglycemia Specialties of internal medicine RC581-951
spellingShingle	Diabetes Mellitus Long-acting Insulin Hypoglycemia Specialties of internal medicine RC581-951 Chan WB Chen JF Goh SY Vu TTH Isip-Tan IT Mudjanarko SW Bajpai S Mabunay MA Bunnag P Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
description	Wing Bun Chan,1 Jung Fu Chen,2 Su-Yen Goh,3 Thi Thanh Huyen Vu,4 Iris Thiele Isip-Tan,5 Sony Wibisono Mudjanarko,6 Shailendra Bajpai,7 Maria Aileen Mabunay,7 Pongamorn Bunnag8 1Qualigenics Diabetes Centre, Hong Kong SAR, People’s Republic of China; 2Division of Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan; 3Department of Endocrinology, Singapore General Hospital, Singapore; 4Out-patient Department and Department of Internal Medicine, National Geriatric Hospital, Hanoi Medical University, Hanoi, Vietnam; 5Section of Endocrinology, Diabetes and Metabolism, University of the Philippines–Philippine General Hospital, Manila, Philippines; 6Diabetes and Nutrition Centre, Dr. Soetomo Hospital, School of Medicine Airlangga University, Surabaya, Indonesia; 7Sanofi, Singapore; 8Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand Abstract: Basal insulin therapy can improve glycemic control in people with type 2 diabetes. However, timely initiation, optimal titration, and proper adherence to prescribed basal insulin regimens are necessary to achieve optimal glycemic control. Even so, glycemic control may remain suboptimal in a significant proportion of patients. Unique circumstances in Asia (eg, limited resources, management of diabetes primarily in nonspecialist settings, and patient populations that are predominantly less educated) coupled with the limitations of current basal insulin options (eg, risk of hypoglycemia and dosing time inflexibility) amplify the challenge of optimal basal insulin therapy in Asia. Significant progress has been made with long-acting insulin analogs (insulin glargine 100 units/mL and insulin detemir), which provide longer coverage and less risk of hypoglycemia over intermediate-acting insulin (Neutral Protamine Hagedorn insulin). Furthermore, recent clinical evidence suggests that newer long-acting insulin analogs, new insulin glargine 300 units/mL and insulin degludec, may address some of the unmet needs of current basal insulin options in terms of risk of hypoglycemia and dosing time inflexibility. Nevertheless, more can be done to overcome barriers to basal insulin therapy in Asia, through educating both patients and physicians, developing better patient support models, and improving accessibility to long-acting insulin analogs. In this study, we highlight the unique challenges associated with basal insulin therapy in Asia and, where possible, propose strategies to address the unmet needs by drawing on clinical experiences and perspectives in Asia. Keywords: insulin titration, insulin detemir, insulin glargine, insulin degludec, patient education
format	article
author	Chan WB Chen JF Goh SY Vu TTH Isip-Tan IT Mudjanarko SW Bajpai S Mabunay MA Bunnag P
author_facet	Chan WB Chen JF Goh SY Vu TTH Isip-Tan IT Mudjanarko SW Bajpai S Mabunay MA Bunnag P
author_sort	Chan WB
title	Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
title_short	Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
title_full	Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
title_fullStr	Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
title_full_unstemmed	Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
title_sort	challenges and unmet needs in basal insulin therapy: lessons from the asian experience
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/8776fe53e18f444398df06aa8b338b82
work_keys_str_mv	AT chanwb challengesandunmetneedsinbasalinsulintherapylessonsfromtheasianexperience AT chenjf challengesandunmetneedsinbasalinsulintherapylessonsfromtheasianexperience AT gohsy challengesandunmetneedsinbasalinsulintherapylessonsfromtheasianexperience AT vutth challengesandunmetneedsinbasalinsulintherapylessonsfromtheasianexperience AT isiptanit challengesandunmetneedsinbasalinsulintherapylessonsfromtheasianexperience AT mudjanarkosw challengesandunmetneedsinbasalinsulintherapylessonsfromtheasianexperience AT bajpais challengesandunmetneedsinbasalinsulintherapylessonsfromtheasianexperience AT mabunayma challengesandunmetneedsinbasalinsulintherapylessonsfromtheasianexperience AT bunnagp challengesandunmetneedsinbasalinsulintherapylessonsfromtheasianexperience
_version_	1718402970088898560

Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience

Ejemplares similares